Trintellix and Vaginal bleeding - a phase IV clinical study of FDA data

Summary:

Vaginal bleeding is reported as a side effect among people who take Trintellix (vortioxetine hydrobromide), especially for people who are 50-59 old, have been taking the drug for < 1 month also take Norco, and have Myeloid leukaemia.

The phase IV clinical study analyzes which people have Vaginal bleeding when taking Trintellix. It is created by eHealthMe based on reports of 12,454 people who have side effects when taking Trintellix from the FDA, and is updated regularly.

What is Trintellix?

Trintellix has active ingredients of vortioxetine hydrobromide. It is often used in depression. eHealthMe is studying from 13,067 Trintellix users. Check the latest studies of Trintellix.

What is Vaginal bleeding?

Vaginal bleeding is found to be associated with 1,129 drugs and 1,538 conditions by eHealthMe. Check the latest studies of Vaginal bleeding.

On Jul, 28, 2026

12,454 people reported to have side effects when taking Trintellix.
Among them, 29 people (0.23%) have Vaginal bleeding.

Could Trintellix cause Vaginal bleeding?

Among these 29 people:

How long have people been on Trintellix when they have Vaginal bleeding? *

What is the age of people who have Vaginal bleeding when taking Trintellix? *

What are other drugs people take besides Trintellix? *

What are other side effects people have besides Vaginal bleeding? *

Abdominal Pain: 11 people, 37.93%
Pain: 9 people, 31.03%
Headache (pain in head): 9 people, 31.03%
Oropharyngeal Pain: 9 people, 31.03%
Inflammation: 8 people, 27.59%
Nausea And Vomiting: 8 people, 27.59%
Nausea (feeling of having an urge to vomit): 8 people, 27.59%
Fatigue (feeling of tiredness): 8 people, 27.59%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 8 people, 27.59%
Influenza Like Illness: 8 people, 27.59%

What are the existing conditions these people have? *

Myeloid Leukaemia (a type of cancer in which the bone marrow makes abnormal myeloblasts): 7 people, 24.14%
Vulvovaginal Pain: 3 people, 10.34%
Sleep Disorder: 3 people, 10.34%
Gastrointestinal Pain: 3 people, 10.34%
Colitis (inflammation of colon): 3 people, 10.34%
Atrophic Vulvovaginitis (inflammation of the vulva): 3 people, 10.34%
Breast Cancer: 2 people, 6.90%
Sinusitis (inflammation of sinus): 1 person, 3.45%
Ovarian Cysts (fluid filled sacs of the ovary): 1 person, 3.45%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 3.45%

* Approximation only. Some reports may have incomplete information.

Do you take Trintellix and have Vaginal bleeding?

- Check whether Vaginal bleeding is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Trintellix:

Trintellix (13,067 reports)

Vaginal bleeding treatments and more:

Vaginal bleeding (49,485 reports)

Browse all side effects of Trintellix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Vaginal bleeding:

Vaginal bleeding (1,129 drugs)

Browse all the conditions that are associated with Vaginal bleeding:

Vaginal bleeding (1,538 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on vortioxetine hydrobromide (the active ingredients of Trintellix) and Trintellix (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.